DRUG

DRUG

Bright Minds Biosciences Inc. Common Stock

$28.380+0.000 (0.000%)

Preço em tempo real

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$28.380

Máximo

$28.380

Mínimo

$28.380

Volume

0.01M

Fundamentos da empresa

Estatísticas de negociação

Notícias relacionadas

GlobeNewswire

Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference

NEW YORK and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. ("Bright Minds," "BMB" or the "Company") (NASDAQ:DRUG), a pioneering company focused on developing highly

Ver mais
Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference
Analyst Upgrades

Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside

Chardan initiates Bright Minds with a Buy rating, citing over $1 billion sales potential for epilepsy drug BMB-101 despite limited clinical data.

Ver mais
Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.